Kathrin Copley, PhD, MBA

Senior Director of Regulatory Affiars



Dr. Copley received her Ph.D. in biochemistry from the University of Nevada, Reno and her MBA from The University of California, San Diego Rady School of Management.  She has over 21 years of experience in all phases of pharmaceutical drug development and laboratory management.  Prior to her position at Allele Biotech, Dr. Copley founded a technical consulting company to assist start-up and early stage companies in drug development, bioanalytical and non-clinical activities.  In addition, Dr. Copley previously worked at Amylin Pharmaceuticals where she was an integral part of the team responsible for both the Byetta and Symlin approvals from the FDA. Back ->